| Style | Citing Format |
|---|---|
| MLA | Kolahi S, et al.. "Diffuse Idiopathic Skeletal Hyperostosis in the Oncologic Population: A Cross-Sectional Analysis of 1053 Patients." Seminars in Arthritis and Rheumatism, vol. 76, no. , 2026, pp. -. |
| APA | Kolahi S, Shakiba M, Rahmani S, Sheybani SN, Seyedi D, Abdelmalik H, Parviz S, Malek M, Kuperus JS, Tahamtan M (2026). Diffuse Idiopathic Skeletal Hyperostosis in the Oncologic Population: A Cross-Sectional Analysis of 1053 Patients. Seminars in Arthritis and Rheumatism, 76(), -. |
| Chicago | Kolahi S, Shakiba M, Rahmani S, Sheybani SN, Seyedi D, Abdelmalik H, Parviz S, Malek M, Kuperus JS, Tahamtan M. "Diffuse Idiopathic Skeletal Hyperostosis in the Oncologic Population: A Cross-Sectional Analysis of 1053 Patients." Seminars in Arthritis and Rheumatism 76, no. (2026): -. |
| Harvard | Kolahi S et al. (2026) 'Diffuse Idiopathic Skeletal Hyperostosis in the Oncologic Population: A Cross-Sectional Analysis of 1053 Patients', Seminars in Arthritis and Rheumatism, 76(), pp. -. |
| Vancouver | Kolahi S, Shakiba M, Rahmani S, Sheybani SN, Seyedi D, Abdelmalik H, et al.. Diffuse Idiopathic Skeletal Hyperostosis in the Oncologic Population: A Cross-Sectional Analysis of 1053 Patients. Seminars in Arthritis and Rheumatism. 2026;76():-. |
| BibTex | @article{ author = {Kolahi S and Shakiba M and Rahmani S and Sheybani SN and Seyedi D and Abdelmalik H and Parviz S and Malek M and Kuperus JS and Tahamtan M}, title = {Diffuse Idiopathic Skeletal Hyperostosis in the Oncologic Population: A Cross-Sectional Analysis of 1053 Patients}, journal = {Seminars in Arthritis and Rheumatism}, volume = {76}, number = {}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Kolahi S AU - Shakiba M AU - Rahmani S AU - Sheybani SN AU - Seyedi D AU - Abdelmalik H AU - Parviz S AU - Malek M AU - Kuperus JS AU - Tahamtan M TI - Diffuse Idiopathic Skeletal Hyperostosis in the Oncologic Population: A Cross-Sectional Analysis of 1053 Patients JO - Seminars in Arthritis and Rheumatism VL - 76 IS - SP - EP - PY - 2026 ER - |